Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Crossover Study of Single and Multiple Dose Pharmacokinetics, and Dose Linearity, of Tolperisone in Healthy Subjects

NCT04465266 is registered in ClinicalTrials.gov with Neurana Pharmaceuticals, Inc. as lead sponsor.

NCT NCT04465266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04465266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Crossover Study of Single and Multiple Dose Pharmacokinetics, and Dose Linearity, of Tolperisone in Healthy Subjects
Lead sponsor
Neurana Pharmaceuticals, Inc.
Phase
Phase 1
Overall status
Completed
Start date
July 28, 2020
Completion date
September 1, 2021
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy